Pharma Journalist -

PCI Pharma Services (PCI) announced the acquisition of Bellwyck Pharma Services (Bellwyck), headquartered in Toronto, Canada. With 25 years of experience, Bellwyck is a leader in…
Read More...

Seattle Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Company’s New Drug Application (NDA) for the investigational…
Read More...

Soligenix, Inc. announced that its RiVax (heat stable ricin toxin vaccine) development program for prevention of ricin intoxication has received "Fast Track" designation from the US…
Read More...

Vir Biotechnology, Inc. a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious diseases, announced that it has identified two…
Read More...

Comar, a specialty packaging, device, and component supplier serving the Medical, Pharmaceutical, Consumer Healthcare, Personal and Home Care, Food and Beverage, and other niche market…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the pivotal Phase 3 KEYNOTE-355 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with…
Read More...

OSE Immunotherapeutics announced a new collaboration agreement with deep technology innovative start-up MAbSilico, located in Tours, France, to use artificial intelligence (AI)-based…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that it has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business in India and…
Read More...

ALX Oncology announced the closing of a $105 million Series C equity financing. Vivo Capital was the lead investor with other new investors including funds managed by Logos Capital,…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) New Drug Application (NDA). Capmatinib is a MET inhibitor…
Read More...